Belgium started reimbursement for teleconsultations on COVID-19

01

Apr 2020

Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) has introduced two new service codes for doctors’ teleconsultation regarding COVID-19. INAMI Insurance Committee established a reimbursement fee of €20.

INAMI-RIZIV has modified Protocol on doctors' fees, prices and reimbursements for visits and consultations, in which stated, that from 14.03.2020 doctors are paid for the consultations they make by telephone in the context of the COVID-19 crisis

New INAMI pseudonomenclature codes came into force on 14.03.2020

  • 101990 Advice for COVID-19 sorting (Avis en vue du triage COVID-19)
  • 101135 Advice for continuity of care (Avis en vue de la continuité des soins)

Doctors charge the reimbursement fee of €20 for these services directly from the patient's mutual fund via the third-party payment system. Doctors cannot charge any supplement. Patients pay nothing.

This measure allows doctors to give medical advice by phone in 2 situations related to the COVID-19 crisis:

  • To "sort out" and guide patients potentially affected by COVID-19
  • To maintain continuity of care for patients, especially those suffering of a chronic disease, who can not attend their doctor because of the directives given within the framework of COVID-19 (immunosuppression, elderly, etc.)

If a sickness certificate is required, doctors can use the new model adapted incapacity for work certificate, which can be transmitted more easily and more quickly in this context of COVID-19.

INAMI is also continuing to examine how it can support other healthcare providers in their fight against COVID-19.

See the full details in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more